SAN DIEGO, June 25, 2025--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment ...

A positron-emission tomographic (PET) image (Panel B) shows corresponding increased fluorodeoxyglucose (FDG) uptake in the pericardium (black arrow) and pleura (white arrows).